Ikarian Capital, LLC Cure Vac N.V. Put Options Transaction History

Ikarian Capital, LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Aug 16, 2021	SELL	$56.91 - $127.53 $20.5 Million - $45.9 Million	-360,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$79.79 - $126.29 $7.88 Million - $12.5 Million	98,800 Added 37.83%	360,000 $32.9 Million
Q4 2020 Feb 12, 2021	BUY	$46.76 - $136.27 $12.2 Million - $35.6 Million	261,200 New	261,200 $21.2 Million

12.2M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $716M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.